Continuous hemofiltration of low molecular protein (CHF-LP) in patients at high risk of liver failure after hepatectomy

肝切除术后肝功能衰竭的正确处理取决于对这些异常背后的机制的理解，以防止多器官功能衰竭的发展，并对已经发生某些器官损害的患者进行最佳管理。然而，肝切除术后肝功能衰竭的发病通常是多器官功能衰竭，可能是由于肝脏与其他器官的相互作用。因此，过度肝切除术的患者在术后第一天使用EVAL二级膜过滤器进行血液滤过以去除炎症介质。肝脏参数显著改善，效果持续数天，即使血液滤过只进行了一天。这些结果表明，在肝切除术后的第一天，使用EVAL二级膜过滤器的血液过滤消除了炎症介质。

The correct management of postoperative hepatic failure following heaptectomy depends on an understanding of the mechanisms behind these abnormalities both to prevent the development of multiorgan failure and to optimally manage patients in whom some organ damage has already developed. However, the onset of the postoperative hepatic failure following hepatectomy usually proceed to multiorgan failure, maybe due to liver to other organ interaction. Thus, patients in whom excessive hepatectomy were carried out, were treated by a hemofiltration using the EVAL secondary membrane filers to remove inflammatory mediators on first postoperative day. Dramatic improvements were seen in hepatic parameters, and the effects were lasting for several days, even though the hemofiltration had been carried out only one day. These resulsts suggested that the hemofiltration using the EVAL secondary membrane filers removed inflammatory mediators on first postoperative day after hepatectomy.